Seroclearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in hepatitis B virus patients during nucleoside/nucleotide analog therapy
Watanabe, H.; Ueno, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 459-465
2015
ISSN/ISBN: 0047-1852 PMID: 26845978 Document Number: 684733
Document emailed within 1 workday
Related Documents
El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312Jiang, M.D. 1993: Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 73(3): 131-134; 189
Xu, X-Wei.; Chen, Y-Gang. 2006: Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B Hepatobiliary and Pancreatic Diseases International: Hbpd Int 5(3): 350-359
Pawłowska, M.łg.; Halota, W. 2011: Long-term therapy with nucleoside analog entecavir (baraclude) in patients with chronic hepatitis B Przeglad Epidemiologiczny 65(2): 313-317
Wu, P.C. 1979: Patterns of hepatitis B surface antigen. Localization in cells of hepatocellular carcinoma Archives of Pathology and Laboratory Medicine 103(4): 165-168
Kondo, M.; Sueta, S.; Oida, E.; Tagawa, M. 2015: A case report of hepatitis B virus reactivation in a hepatitis B core antibody-positive, hepatitis B surface antigen-negative hemodialysis patient Nihon Jinzo Gakkai Shi 57(8): 1363-1368
Tu, H.; Gao, H.-f.; Ma, G.-h.; Liu, Y. 2006: Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B Zhonghua Yi Xue Za Zhi 86(18): 1249-1252
Huang, M.J.; Liaw, Y.F. 1990: Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma American Journal of Gastroenterology 85(3): 281-284
Koyama, H.; Nishizawa, Y.; Kinoshita, H.; Fujimoto, T.; Morii, H. 1988: Hepatocellular carcinoma with occult chronic hepatitis--hepatitis B virus as a pathogenetic factor of hepatocellular carcinoma Osaka City Medical Journal 34(1): 51-66
Komorizono, Y.; Sako, K.; Yamasaki, N.; Hiwaki, T.; Sakurai, K.; Shibatou, T.; Maeda, M.; Kohara, K.; Shigenobu, S.; Hasegawa, S.; Arima, T.; Oketani, M.; Ishibashi, K.; Arima, T. 2002: Outcome of patients with hepatitis C virus-related hepatocellular carcinoma occurring after interferon therapy Anticancer Research 22(6b): 3573-3578
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Chiba, T.; Matsuzaki, Y.; Abei, M.; Shoda, J.; Tanaka, N.; Osuga, T.; Aikawa, T. 1996: The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma American Journal of Gastroenterology 91(6): 1195-1203
Myl'nikov, A.I.; Lytsar', B.N.; Gorbatok, L.E.; Skvortsov, S.V.; Poliakova, I.I.; Gorbatiuk, V.I. 1994: The detectability of the hepatitis B surface antigen and antibodies to the hepatitis C virus in serviceman blood donors Voenno-Meditsinskii Zhurnal 3: 44-45; 79
Tarao, K.; Ohkawa, S.; Tamai, S.; Shimizu, A. 1995: Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 740-745
Nayersina, R.; Fowler, P.; Guilhot, S.; Missale, G.; Cerny, A.; Schlicht, H.J.; Vitiello, A.; Chesnut, R.; Person, J.L.; Redeker, A.G.; Chisari, F.V. 1993: HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection Journal of Immunology 150(10): 4659-4671
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Hirano, Y. 1982: Hepatitis-associated antigen and antibody in patients with hepatocellular carcinoma Rinsho Byori. Japanese Journal of Clinical Pathology 30(7): 758-763
Shapiro, I.I.; Shabrov, A.V.; Karev, V.E.; Leenman, E.E.; Kvetnoĭ, I.M.; Tsinzerling, V.A.; Sologub, T.V. 2005: Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus Arkhiv Patologii 67(2): 6-10
Leone, N.; Rizzetto, M. 2005: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma Minerva Gastroenterologica E Dietologica 51(1): 31-46